B

Beatriz Aranda-Orgillés

Intellicell Biosciences (United States)

ORCID: 0000-0002-8940-1884

Publishes on CAR-T cell therapy research, RNA modifications and cancer, Acute Myeloid Leukemia Research. 41 papers and 1.9k citations.

PubIndex Score52Top 48% · mid-careerHow it's scored

41Publications

1.9kTotal Citations

First publication: 2008First senior author: 2023

CAR-T cell therapy research RNA modifications and cancer Acute Myeloid Leukemia Research Protein Degradation and Inhibitors Epigenetics and DNA Methylation

Top publicationsby citations

Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancer

Piril Erler, Beatriz Aranda-Orgillés|Science Advances|2024

Cited by 33

Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies

Beatriz Aranda-Orgillés, Laurent Poirot|Cancer Immunology Research|2023

Cited by 9